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Background: The objective of this study was to evaluate the host response to an interspinous process 
device [Device for Intervertebral Assisted Motion (DIAM®)] based on a series of nine spine explants with a 
mean post-operative explant time of 35 months. 
Methods: Explanted periprosthetic tissues were processed for histology and stained with H&E, Wright-
Giemsa stain, and Oil Red O. Brightfield and polarized light microscopy were used to evaluate the host 
response to the device and the resultant particulate debris. The host response was graded per ASTM F981-
04. Quantitative histomorphometry was used to characterize particle size, shape, and area per ASTM F1877-
05. The presence or absence of bone resorption was also evaluated when bony tissue samples were provided.
Results: Periprosthetic tissues demonstrated a non-specific foreign body response composed of 
macrophages and foreign body giant cells to the DIAM® device in most of the accessions. The foreign 
body reaction was not the stated reason for explantation in any of the accessions. Per ASTM F981-04, a 
“very slight” to “mild” to “moderate” chronic inflammatory response was observed to the biomaterials and 
particulate, and this varied by tissue sample and accession. Particle sizes were consistent amongst the explant 
patients with mean particle size on the order of several microns. Osteolysis, signs of toxicity, necrosis, an 
immune response, and/or device related infection were not observed. 
Conclusions: Cyclic loading of the spine can cause wear in dynamic stabilization systems such as DIAM®. 
The fabric nature of the DIAM® device’s polyethylene terephthalate jacket coupled with the generation of 
polymeric particulate debris predisposes the device to a foreign body reaction consisting of macrophages 
and foreign body giant cells. Although not all patients are aware of symptoms associated with a foreign body 
reaction to a deeply implanted device, surgeons should be aware of the host response to this device.
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Introduction
Lumbar spinal stenosis (LSS) is a common clinical scenario 
with a prevalence of 20–25% in the general population (1). 
Clinically, LSS presents as back or leg pain that is primarily 
related to position or posture and is caused by a reduction 
in the volume of the spinal canal and compression on 
the thecal sac or exiting nerve roots. LSS is the most 
common reason for back surgery in people over the age 
of 65 in the United States (2). Surgical treatment for LSS 
is considered when conservative treatments fail to relieve 
pain and improve function. The current surgical standard 
is decompression via posterior decompressive laminectomy 
with or without fusion. The success rate of this procedure 
varies in the literature; however, recent clinical trials have 
suggested surgical treatment to be superior to non-operative 
management (3). As an alternative to wide decompressive 
laminectomy, interspinous process devices (IPDs) have been 
designed to treat patients with LSS by limiting extension.  
IPDs are a type of dynamic stabilization (non-fusion) 
devices that are widely used in Europe for the treatment 
of LSS. In contrast to laminectomy with fusion or disc 
arthroplasty devices, IPDs can be implanted using a 
minimally invasive approach. After removal of a portion of 
the interspinous ligament, IPDs are surgically implanted 
into the interspinous space in order to induce local 
distraction of the posterior elements. The purposes of these 
devices are to provide stabilization after decompression, 
to effect local segmental lumbar kyphosis, to restore 
foraminal height, and to unload the facet joints (4). While 
they primarily limit extension at the treated level, IPDs 
allow for the preservation of range of motion (ROM) in 
other directions at the implanted level. Multiple authors 
have undertaken biomechanical studies and performed 
finite element analyses to assess the effect of IPDs on spine 
segment range of motion, local kyphosis, and intradiscal 
pressure (5-9). Biomechanical studies and finite element 
analysis of IPDs have shown a decrease in intradiscal 
pressure both at the implanted level as well as at adjacent 
levels, thus avoiding increased biomechanical loads being 
transmitted to adjacent segments (7-8,10). 
The DIAM® (Device for Intervertebral Assisted Motion) 
spinal stabilization system (Medtronic, Ltd.) is an X-shaped 
elastomeric IPD. The literature indicates that the DIAM® 
device was developed by Dr. Jean Taylor (11). In 2007, Taylor 
et al. suggested three indications for the DIAM® device: 
“The first indication is for discogenic disease, either primary or 
recurrent, with or without discectomy. The second indication is for 
posterior disease resulting in central stenosis, foraminal stenosis, 
facet disease, or ligamentous instability leading to no more than a 
Grade I spondylolisthesis. The third indication is to protect from 
junction disease by implanting a DIAM® above a fresh or existing 
lumbar fusion.” (11) The thought behind IPDs as dynamic 
stabilization devices revolves around the biomechanical 
change of load transmission in the spine with the IPD 
functioning as a load-sharing device within the spinal 
column. In addition, by securing the spinous processes of the 
posterior aspect of the functional spinal unit, they provide 
distraction of the segment and are meant to reduce extension 
of the treated segment. In providing distraction of the spinal 
segment, the literature suggests that these devices may also 
increase the neuroforaminal space (10,12,13).
There have been multiple investigations into the clinical 
outcomes associated with the DIAM® device (11,14-19). 
Taylor et al. conducted a retrospective chart review and 
follow-up questionnaire for 104 patients who received the 
DIAM® device during 2001 (11). The pain level showed 
improvement in 88.5% of the patients (11). Devices are 
deemed to be efficacious if their use is associated with a 
significant palliative effect. In this regard, pain levels as 
measured by visual analog scale (VAS) have been shown to 
decrease significantly following implantation of DIAM® 
devices (12,14,18,19). Buric et al. studied 52 consecutive 
patients implanted with DIAM® devices for low back 
pain due to degenerative disc disease (14). In their series, 
88% of patients were considered as success (defined as 
a ≥30% of improvement as calculated on the Roland 
Morris Disability Questionnaire scale comparing the 
24 months values to the baseline values) (14). Fabrizi 
examined a series of 1,315 consecutive patients who 
underwent DIAM® implantation (15). Using the modified 
Macnab criteria, symptoms resolution or improvement was 
rated as excellent or good in 89% of the patients (15). When 
comparing DIAM® implantation to traditional decompressive 
surgery, Wu et al. found no significant difference between 
the groups for low back pain, leg pain, or complications (20). 
The traditional decompressive group had a significantly 
lower incidence of reoperation (20). Wu et al. concluded that 
although patients may obtain some benefits from interspinous 
spacers implanted through a minimally invasive technique, 
interspinous spacer use is associated with a higher incidence 
of reoperation and higher cost (20).
All of these data suggest that the DIAM® device does 
participate in the biomechanical load share in the spine and 
can partially unload the intervertebral disc. In nonclinical 
animal and cadaver studies as well as clinical studies, multiple 
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authors have shown decrease in range of motion of the 
treated level with the DIAM® device, especially in extension, 
without significantly increased ranges of motion at adjacent 
levels. This decreased range of motion at the index level 
appears to be maintained at least 2 years post-operatively, 
and the concomitant restriction of motion with unloading of 
the disc is likely the biomechanical benefit of the device. The 
literature also shows that the DIAM® device can realign facet 
joints and increase neuroforaminal space in the post-operative 
period, although some studies have shown a decrease in 
posterior disc height and neuroforaminal height as a function 
of time. Most authors also reported statistically significant 
long-term decreased pain (VAS) scores and Oswestry 
Disability Index (ODI) scores associated with implantation 
of the DIAM® device, with post-operative pain decreasing 
significantly in the immediate post-operative timeframe 
(1–2 weeks) and then continuing at the low levels for the 
duration of the study. When using the tethers as part of 
the surgical protocol associated with the DIAM® device, 
the literature supports that the lordotic angle seems to 
be flattened in the immediate post-operative timeframe 
(1–2 weeks) although this may not be maintained long term. 
Despite this, long-term pain (VAS) scores associated with 
implantation of the DIAM® device are decreased, which 
would seem to indicate that changes to lordotic angle alone 
are not associated with patient pain. Based on these studies, 
it seems that decreased patient pain correlated the best with 
decreased range of motion. Reporting of adverse events or 
secondary surgery associated with the DIAM® device varied 
widely, with some studies reporting little to no incidences 
and other studies reporting up to 20%.
While the clinical performance of the DIAM® is 
summarized above, little is known about the host response 
to this device. It is known that cyclic loading of the spine can 
cause wear of a dynamic stabilization system, of which DIAM® 
is an example. None of the existing literature characterizes 
the particulate debris from these devices. The objective of 
this study was to evaluate the host response to the DIAM® 
device based on a series of nine spine explants with a mean 
post-operative explant time of 35 months. Quantitative 
histomorphometry was also performed to characterize 
polymeric particulate debris in periprosthetic tissues.
Methods
The DIAM® device
The DIAM® device is an X-shaped elastomeric interspinous 
spacer implant made of a polyester [polyethylene terephthalate 
(PET)] fabric jacket and a silicone (polydimethylsiloxane) core 
and secured in place with two braided polyester (PET) tethers 
with titanium crimps. Although used in Europe, the DIAM® 
device is not currently approved for use in the United States. 
Outside the United States, the indications for use listed by the 
device manufacturer include: LSS, herniated and degenerated 
lumbar disc, facet joint pain syndrome and minor degenerative 
spondylolisthesis. During the clinical trial in the US, the 
proposed indication for use of the DIAM device was “for 
skeletally mature patients that have moderate low back pain (with 
or without radicular pain) with current episode lasting less than one 
year in duration secondary to lumbar degenerative disc disease (DDD) 
at a single symptomatic level from L2-L5”. Figure 1A shows the 
DIAM® device and tethers.
Explant analysis
The primary purpose of our explant study is to evaluate 
the host response to retrieved spine devices by performing 
histological analyses on peri-prosthetic tissues. This analysis 
is covered under the expedited IRB Protocol entitled, 
“Histologic Evaluation of Retrieved Spine Devices” (HRRC 
239-03). Our retrieval analysis study is designed to evaluate 
the type of tissues adjacent to retrieved devices, look for the 
presence or absence of wear debris, and characterize the 
inflammatory response adjacent to the device and debris 
(if present). Retrieval studies supplement what is learned 
from the patient’s pathology report, but are not in lieu of 
pathology (21). Retrieval studies are a unique opportunity 
to assess the host response to implanted biomaterials. 
Over a 10-year period, we received a total of ten accessions 
from DIAM® patients as summarized in Table 1. The reason 
for device explantation is also summarized in Table 1. The 
accession date was used as the identifier on all records, 
histology slides, and digital images. The DIAM® accessions 
were from patients in two US clinical trials sponsored by 
Medtronic Spine (8) or accessions from patients outside 
the US (2) where the device is approved. Medtronic Spine 
obtained patient consent for all explant cases. In addition, the 
principles set forth in the Declaration of Helsinki as well as 
the US Code of Federal Regulations, Title 45, Part 46, on 
Protection of Human Subjects were followed.
Of the ten accessions associated with the DIAM® devices, 
one accession consisted of a wound debridement with skin 
and subcutaneous tissues without an explanted device and 
without periprosthetic tissues. In one additional accession, 
just the device was received without periprosthetic tissues. 
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Figure 1 This Figure shows an unimplanted DIAM® device and the gross appearance of the explanted DIAM® devices. (A) Unimplanted 
DIAM® device; (B) gross appearance of a DIAM® device explanted at 7 post-operative months; (C) gross appearance of a DIAM® device 
explanted at 15 post-operative months; (D) gross appearance of a DIAM® device explanted at 43 post-operative months; (E) appearance of a 
formalin-fixed DIAM® device explanted at 120 post-operative months.
Therefore, a total of eight accessions with periprosthetic 
tissues and DIAM® devices ranging between seven and 
120 post-operative months were received. The mean time 
between implantation and explantation of the DIAM® 
device and periprosthetic tissue samples was 35 months. 
The determination of the materials response (material 
properties of the implant material as defined in ASTM 
F561-05) was not performed in our laboratory (22). 
Histologic evaluation
Decalcified/paraffin histological analyses was used to assess 
the host response to the explanted IPDs. Routine H&E 
staining was performed. In addition, Oil Red O special 
staining was performed. Oil Red O staining is frequently 
used for the demonstration of polymeric particulate debris in 
periprosthetic tissues associated with joint arthroplasty (23). 
Additional special staining included Mallory Aniline Blue 
Connective tissue stain and Wright-Giemsa staining. The 
degree of inflammatory host response to the device and 
particulate debris was graded per ASTM F981-04 (24). 
Quantitative histomorphometry of particulate debris
In three of the patients in which particulate debris 
was observed in periprosthetic histology, quantitative 
histomorphometry of particulate debris was conducting 
using image analysis software (Image Pro Premier 9.04, 
Media Cybernetics, Silver Spring, MD, USA). Briefly, 
spatial calibration was conducted using a micrometer slide 
at a consistent magnification of 200×. This consistent 
magnification allowed for sufficient sampling of numerous 
particles in the periprosthetic histology. Microscopic fields 
for particle size analysis were not randomly selected. Seven 
to 11 microscopic fields per explant patient were selected 
for analysis if they contained large numbers of birefringent 
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polymeric particulate for characterization. Measurements 
included: minimum caliper width, maximum caliper length, 
mean caliper length, polygonal area of the particle, particle 
aspect ratio, particle width, and particle length. Particle 
ranges (measurement filters) were set between 0.5 and 
200 μm for most of these parameters. Particle size and shape 
measurements were transferred from the image analysis 




The gross appearance of the explanted DIAM® devices is 
seen in Figure 1B,C,D,E. Six of the nine explanted DIAM® 
devices had tears in the fabric jacket, and in two instances, 
the silicone core was separated from the PET fabric jacket. 
It is not known if this occurred during explantation of 
the device, or during service in vivo. When exposed, the 
polydimethylsiloxane elastomeric core of the device had a 
purplish discoloration at gross. In two of the nine explanted 
DIAM® devices, the polydimethylsiloxane elastomer core 
of the device was fragmented, and in both instances, this 
was observed as a separation of one of the wings from the 
core of the silicone device. It is not known if this occurred 
during explantation or during service in vivo. 
Radiographic 
The radiographic appearance of the explanted DIAM® 
devices is seen in Figure 2. Four out of the five explanted 
DIAM® devices had radiopacity of the fabric jacket 
consistent with calcification or bone on the fabric jacket at 
the intersection of the superior and inferior wings, as seen 
in Figure 2A,B. 
Histologic results
Most of the periprosthetic tissue samples consisted of 
a mix of connective tissues, with fibrous tissues and 
bone predominating. At early time points and in some 
microscopic fields, fibroblasts and fibrous connective 
tissues surrounded the PET fibers of the fabric jacket of 
the DIAM® device. As seen in Figure 3A, a foreign body 
response to the fabric jacket is not observed at seven post-
operative months. PET fibers did not stain red with Oil Red 
O when viewed with transmitted light as seen in Figure 3B. 






















080508 11 Periprosthetic Unknown Yes No V. Slight No No




debridement for superficial 
wound infection
No No N/A No No
120808 7 Periprosthetic Leg pain/radiculopathy No Yes V. Slight No No
050409 15 Periprosthetic Leg pain/radiculopathy No No None Yes No
052709 16 Periprosthetic Trauma Yes Yes Mild No No
022811 32 Periprosthetic Adjacent level stenosis 
with repeat decompression
Yes Yes Moderate Yes Yes
092211 25 Periprosthetic Facet arthropathy and 
instability (anterolisthesis)
Yes Yes Mild Yes No
041312 22 None provided Recurrent back pain N/A N/A N/A N/A N/A
061112 43 Periprosthetic Leg pain/radiculopathy Yes Yes Mild No No
022018 120 Periprosthetic Progressive spine 
destabilization requiring 
instrumented fusion
Yes Yes Mild No No
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In Figure 3B, red stained silicone particulate debris is 
observed intracellularly within macrophages and foreign 
body giant cells at 43 post-operative months. When viewed 
with polarized light, PET fibers were birefringent as seen 
in Figure 3C. The red stained silicone particulate was not 
birefringent when viewed with polarized light, as seen in 
Figure 3C. Since the silicone used in the DIAM® device is 
an amorphous (non-crystalline) polymer, and the PET used 
in the DIAM® device is a crystalline polymer, polarized 
light microscopy can readily distinguish these two polymers 
in periprosthetic histology. In addition to the foreign body 
host response to the PET fibers, a fibrous capsule was 
observed to surround the PET fibers of the DIAM® device 
in the histology. 
Six of the 8 accessions which included periprosthetic 
tissue samples showed particulate debris in peri-implant 
tissues as seen in Table 1. The nonpolarizable silicone 
particulate debris was surrounded by macrophages as well 
as foreign body giant cells in the histology. Oil Red O 
stained sections demonstrated red foamy macrophages with 
intracellular silicone particulate in periprosthetic tissues 
as seen in Figure 4A. In Figure 4B, red stained silicone 
particulate is observed intracellularly within macrophages 
and foreign body giant cells at 25 post-operative months. As 
BA
Figure 2 Radiographic appearance of explanted DIAM® devices. (A) Radiographic appearance of a DIAM® device explanted at 7 post-
operative months. Arrow shows radiopacity consistent with apparent calcification or bone on the fabric; (B) radiographic appearance of a 
DIAM® device explanted at 43 post-operative months. Arrows show radiopacity consistent with apparent calcification or bone on the fabric.
B CA
Figure 3 Histology showing response to polyethylene terephthalate (PET) fibers. (A) Fibroblasts and fibrous connective tissue are seen 
adjacent to the PET fibers at 7 post-operative months. No foreign body response is observed (Wright-Giemsa stain, original magnification 
=200×); (B) host response to PET fibers at 43 post-operative months. Note that the PET fibers are not stained red. No foreign body 
response is observed. Red stained polydimethylsiloxane (silicone) intracellular particulate debris is observed adjacent to the PET fibers (yellow 
arrows) (Oil Red O/hematoxylin stain, original magnification =79×); (C) same field in Figure 3B but viewed under partially polarized light. 
The PET fibers are birefringent. Note that the red stained polydimethylsiloxane (silicone) intracellular particulate debris observed adjacent 
to the PET fibers is not birefringent (arrows) (Oil Red O/hematoxylin stain, original magnification =79×, partially polarized light).
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Figure 4 Histology showing response to polydimethylsiloxane (silicone). (A) Host response to polydimethylsiloxane (silicone) at 32 post-
operative months. Red stained silicone intracellular particulate debris is observed within foamy macrophages in intertrabecular spaces. 
Several lymphocytes are also observed in the periprosthetic tissues (Oil Red O/hematoxylin stain, original magnification =500×); (B) host 
response to polydimethylsiloxane (silicone) at 25 post-operative months. Red stained silicone intracellular particulate debris is observed 
within foamy macrophages and foreign body giant cells. Birefringent polyethylene terephthalate (PET) debris is also observed within 
foamy macrophages and foreign body giant cells (Oil Red O/hematoxylin stain, original magnification =200×, partially polarized light); (C) 
host response to particulate debris at 32 post-operative months. Intracellular particulate debris is observed within foamy macrophages in 
intertrabecular spaces (H&E stain, original magnification =200×); (D) rotated field in Figure 4C but viewed under partially polarized light. 
The intracellular PET particulate debris within macrophages and foreign body giant cells is birefringent (H&E stain, original magnification 
=200×, partially polarized light).
seen in Figure 4B, PET particulate debris was birefringent 
when viewed with polarized light. The red stained silicone 
particulate was not birefringent when viewed with polarized 
light, as seen in Figure 4B. In addition to being found 
adjacent to the implant, foamy macrophages and foreign 
body giant cells were also found in intertrabecular spaces 
as seen in Figure 4C. The same microscopic field from an 
adjacent serial section viewed with polarized light is seen 
in Figure 4D, and birefringent PET particulate is observed 
intracellularly within these foamy macrophages and foreign 
body giant cells. Despite the presence of this particulate 
debris, osteoclastic resorption of bone is not observed on 
adjacent bony trabeculae in Figure 4C. 
In two of the eight explants with periprosthetic tissues, 
a foreign body response was not observed in the histology. 
In six of the eight explants, histology of the periprosthetic 
tissues demonstrated a non-specific foreign body response. 
Figure 5A shows a sample micrograph demonstrating a 
foreign body response to the PET fibers and polymeric 
debris with several foreign body giant cells at 25 post-
operative months. Figure 5B,C show sample micrographs 
demonstrating a foreign body response at 16 and 
120 post-operative months to the non-birefringent silicone 
debris. The host response was composed of macrophages 
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Figure 5 Histology showing foreign body response to implant. (A) Foreign body giant cell response to polyethylene terephthalate (PET) 
fibers and particulate debris at 25 post-operative months (H&E stain, original magnification =200×); (B) foreign body giant cell response 
to non-birefringent silicone particulate debris and birefringent PET particulate debris at 16 post-operative months (Wright-Giemsa stain, 
original magnification =200×, partially polarized light); (C) foreign body giant cell response to non-birefringent silicone particulate debris 
in the interstices of fibrous connective tissues at 120 post-operative months (H&E stain, original magnification =200×, partially polarized 
light); (D) asteroid body (arrow) within a foreign body giant cell as part of a foreign body response to polymeric particulate debris at 32 post-
operative months (H&E stain, original magnification =500×).
with foreign body giant cells predominating. As seen in 
Figure 5D, asteroid bodies within foreign body giant cells 
was observed in one patient at 32 post-operative months. 
No plasma cells or neutrophils were observed in the explant 
histology. Typically, less than five eosinophils and less than 
five lymphocytes per high power field were observed in 
periprosthetic tissues. There was no evidence of toxicity, 
necrosis, device related infection, or an immune response in 
the histology of periprosthetic tissues. Fluid accumulation 
was not observed adjacent to the explanted DIAM® 
devices in the current series of explants. Between 0 to 
25 macrophages and between 0 to 15 foreign body giant 
cells per high power field (400–500×) were observed 
adjacent to the polymeric device and polymeric particulate 
debris in peri-prosthetic tissues (24). The ASTM F981-
04 scores for inflammation by accession and post-operative 
time point are seen in Table 1 (24). Per ASTM F981-04, a 
“very slight” to “mild” to “moderate” chronic inflammatory 
response was observed to the biomaterials in the explant 
histology (24). 
The presence of bony tissue and the presence of bone 
resorption observed in periprosthetic tissues by explant 
accession and post-operative time point is seen in Table 1. 
Three accession contained bone for analysis, and bone 
resorption (not osteolysis) was noted in only one of these 
three accessions. As seen in Figure 6A, quiescent bone 
with hematopoietic marrow in intertrabecular spaces was 
observed adjacent to the IPD at 25 post-operative months. 
Osteoclastic resorption of bone was not observed in this 
explant case. Figure 6B shows bony remodeling consisting 
of osteoblastic activity (yellow arrows) and a small amount 
of osteoclastic resorption (green arrows) of bone adjacent 
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Figure 6 Histology of bony tissues adjacent to the IPD. (A) Quiescent bone with hematopoietic marrow in intertrabecular spaces adjacent 
to the IPD at 25 post-operative months. Osteoclastic resorption of bone is not observed (H&E stain, original magnification =79×); (B) bony 
remodeling consisting of osteoblastic activity (yellow arrows) and a small amount of osteoclastic resorption (green arrows) of bone adjacent 
to the IPD at 32 post-operative months. Osteolysis was not observed (H&E stain, original magnification =79×). IPD, interspinous process 
device.
to the IPD at 32 post-operative months. Osteolysis was not 
observed in any of the histology sections from any of the 
explant accessions. 
Quantitative histomorphometry of particulate debris results
Approximately 3,000 particles were characterized by 
quantitative histomorphometry as each of the three 
accessions had 10 different microscopic fields measured 
with approximately 100 particles within ranges per 
microscopic field. Mean measurements of particle size 
and shape by accession as measured by quantitative 
histomorphometry as well as mean and standard deviations 
for all three patients is seen in Table 2. Particle sizes were 
consistent amongst the three patients with mean particle 
size on the order of several microns. Similarly, the aspect 
ratio of particles was consistent amongst the three patients 
with a mean aspect ratio of 1.98±0.21 for all three patients. 
The particle sizes and shape were consistent with what 
was qualitatively observed in the histology as seen in 
Figures 4,5. Qualitatively, particulate shape of the silicone 
particles in the histology would be best characterized 
as globular per ASTM standard F1877-05 [2010] (25). 
Qualitatively, particulate shape of the polyester particles 
would be best characterized as threadlike fibers or fibrillar 
per ASTM standard F1877-05 [2010] (25). 
Discussion 
Jerosch and Moursi reported a foreign body reaction (FBR) 
after implantation of a DIAM® device. They incorrectly 
attribute the foreign body reaction “due to polyethylene’s 
Table 2 Mean measurements of particle size and shape analysis by accession as measured by quantitative histomorphometry
Measurement 052709 092211 061112 Mean Standard deviation
Minimum caliper width (μm) 2.90 2.44 3.58 2.97 1.24 
Maximum caliper length (μm) 5.31 4.78 6.55 5.56 2.19
Mean caliper length (μm) 4.26 3.76 5.26 4.43 1.77
Polygonal area of the particle (μm2) 27.7 14.5 52.4 31.4 34.7
Particle aspect ratio 2.02 2.03 1.90 1.98 0.21
Particle width (μm) 3.30 2.79 3.91 3.33 1.29
Particle length (μm) 5.10 4.60 6.37 5.37 2.18
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wear” even though the DIAM® device is not fabricated from 
polyethylene (26). Histology revealed particulate debris as 
well as a FBR with macrophages (26). The patient’s pain 
resolved after device removal. Seo et al. report a case of 
FBR to a DIAM® device implanted in a 72-year-old female 
patient who presented with lower back pain and radiating 
pain in both legs 5 years after receiving the DIAM® device 
for spinal stenosis at L4-L5 (27). Removal of the device and 
granulation tissue with subsequent L3-L5 fusion relieved 
her back pain (27). The authors conclude, “In patients with 
a DIAM® who complain of back and radiating pain, a FBR 
must be considered, and the patients should be monitored long 
term.” (27). As seen in Table 1, back or leg pain was the 
reason for DIAM® device explantation in five of our eight 
explant patients; thus, it is possible that the foreign body 
reaction was the cause of this pain. Tamburrelli et al. carried 
out a critical analysis of the causes of failure in a series of 
19 patients whose IPDs (5 DIAM® devices in 4 patients) 
were explanted between 2007 and 2009 (28). With respect 
to the DIAM® device, Tamburrelli et al. reported, “In one 
patient (DIAM®), we found a foreign body reaction to the device 
material. In particular, at surgery, we identified a major local 
tissue reaction surrounding the device. The polyethylene [sic] 
lining of the silicone core was broken. The microscopic examination 
of tissue samples showed the classical features of foreign body 
reaction.” (28). Histology of the periprosthetic tissues 
adjacent to the explanted DIAM® devices demonstrated 
a non-specific foreign body response consisting of 
macrophages and foreign body giant cells in a majority of 
our series of explant patients. The chronic inflammatory 
host response composed of macrophages as well as foreign 
body giant cells is consistent with the generation of 
particulate debris by wear mechanisms in spine arthroplasty 
devices (21,29,30). 
According to pathologist James Anderson, “Most 
biomaterials of potential clinical interest typically elicit the foreign-
body reaction (FBR), a special form of non-specific inflammation. 
The most prominent cells in the FBR are macrophages… 
Multinucleated giant cells in the vicinity of a foreign body are 
generally considered evidence of a more severe FBR.” (29). 
Anderson further states, “Relatively rough surfaces such as those 
found on the outer surfaces of expanded PTFE or Dacron vascular 
prostheses have a foreign body reaction composed of macrophages and 
foreign body giant cells at the surface. Fabric materials generally 
have a surface response composed of macrophages and foreign body 
giant cells…” (29). It should be pointed out here that patients 
may not be aware of any symptoms associated with a FBR to 
a deeply implanted device, and the observed FBR was not the 
stated reason for device explantation in any of our series of 
explant patients as seen in Table 1.
Fluid accumulation was not observed adjacent to the 
explanted DIAM® devices in the current series of explants. 
There have been three journal articles that described fluid 
accumulation associated with DIAM® devices (17,26,31). Two 
of the three articles were single case reports. The third article 
mentioned fluid accumulation in a series of patients (17). 
Out of the thousands of DIAM’s implanted, the reporting of 
this phenomenon in the literature would appear to be very 
low. Lastly, from the cardiovascular literature, the incidence 
of fluid accumulations adjacent to PET vascular grafts is 
reported in less than 1% of patients (32).
Stefanovic et al. describe a single patient’s two DIAM® 
implants and report thick aseptic fluid around the DIAM® 
implants as well as a mineralized pseudocyst around the 
DIAM® devices and adjacent spinous process osteolysis (31). 
Laboratory analyses showed that the patient’s sedimentation 
increased to 47/h, CRP was 11, and there was no change 
in the patient’s white blood cell count (31). Despite these 
laboratory tests, osteolysis of the spinous processes might be 
evidence of infective osteolysis in this case, as it is possible 
the abscesses could have been caused by an infection. In 
fact, the clinicians suspected an infection as they treated 
the patient with 3 courses of antibiotics (31). They indicate 
that the patient’s “pain subsided” after the course of 
antibiotics (31). Although both DIAM® devices were 
explanted, no histopathology of periprosthetic tissues was 
provided in the paper that could indicate an infection, a 
FBR, or particulate debris. Particulate debris of any material 
can show osteolysis. Even though large numbers of DIAM® 
devices have been implanted, osteolysis associated with the 
DIAM® device has not been reported in any other cases in 
the scientific literature. Although not all of our explants 
included bony tissue samples, none of the periprosthetic 
tissue samples associated with our series of explants showed 
evidence of osteolysis. 
We found asteroid bodies within foreign body giant cells 
as part of a foreign body response to polymeric particulate 
debris in one patient at 32 post-operative months. Asteroid 
bodies within foreign body giant cells have been reported 
in the literature for medical devices made from silicone 
biomaterials (33-39). With respect to asteroid bodies, Lasso 
et al. indicate, “Although their presence is not specific, they are 
usually associated with sarcoidosis, tuberculosis, and the reaction of 
foreign bodies.” (35).
The long-term durability of polyester (PET) as 
an implantable biomaterial is in question because of 
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degradation and hydrolysis of polyesters that occurs in 
physiological conditions (40). This degradation is increased 
under mechanical stresses (40). Both in vivo and in vitro 
studies have shown that the cumulative effects of such slow 
degradation processes will ultimately lead to PET vascular 
implant failure via mechanical breakdown (40-42). With 
respect to the lifetime of PET for medical applications, 
Rahman states, “Due to the physical and chemical variability 
within the PET, it is very difficult to estimate how long PET 
implants will last in the physiological conditions. One suggestion 
is that when using PET medical devices for human spare parts, 
the surgeons must be committed to a follow-up of such a patient 
for his/her remaining life. Only by this means will the safety and 
effectiveness of the spare part become known.” (40).
Much of the polymeric particulate debris in the series of 
DIAM® explants was on the order of several microns in size, 
but some smaller particles could have been agglomerated 
or clumped. We used a consistent magnification of 200× to 
conduct the analysis of particle size. Therefore, particles 
smaller than 0.5 μm, if present, were not measured by our 
quantitative histomorphometry technique. While light 
microscopy is not the best tool for evaluating particle 
size and shape, this method nevertheless provided a good 
estimate of particle size, particle area, and aspect ratio. 
The particle sizes and shape as measured by quantitative 
histology were consistent with what was qualitatively 
observed in the histology as seen in Figures 4,5. Therefore, 
particle characterization and measurements for mean 
particle size, aspect ratio, and particle area were reported 
with these discussed limitations in mind. 
Conclusions
Six of the nine explanted DIAM® devices had tears in 
the fabric jacket, and in two instances, the silicone core 
was separated from the PET fabric jacket. In two of the 
nine explanted DIAM® devices, the polydimethylsiloxane 
elastomer core of the device was fragmented, and in both 
instances, this was observed as a separation of one of the 
wings from the core of the silicone device. It is not known 
if these tears and fractures occurred during explantation or 
during service in vivo. Four out of the five explanted DIAM® 
devices had radiopacity of the fabric jacket consistent with 
calcification or bone on the fabric jacket at the intersection 
of the superior and inferior wings. Long-term integrity of 
the fabric jacket may be in question as PET can undergo 
degradation by hydrolysis which can be accelerated by 
mechanical stresses. Similarly, the silicone core component 
may fracture after numerous cycles of loading.
Histology of the periprosthetic tissues adjacent to 
the explanted DIAM® devices demonstrated a non-
specific foreign body response consisting of macrophages 
and foreign body giant cells in most of our series of 
explant patients. The foreign body reaction consisting of 
macrophages and foreign body giant cells is most likely 
associated with: (I) the fabric nature of the polyester jacket 
of the DIAM® device, and (II) the generation of particulate 
debris by wear mechanisms. Back or leg pain was the 
reason for DIAM® device explantation in 5 of our 8 explant 
patients; thus, it is possible that the foreign body reaction 
was the cause of this pain. However, the literature suggest 
that patients may not be aware of symptoms associated 
with a foreign body reaction to a deeply implanted device, 
and in our series of explants, the observed foreign body 
reaction was not the stated reason for device explantation. 
Nevertheless, surgeons should be aware of the host response 
to this device as it may be a possible source of pain.
Cyclic loading of the spine can cause the generation 
of wear debris in dynamic stabilization systems such as 
DIAM®. Particle sizes were consistent amongst the explant 
patients with mean particle size on the order of several 
microns. The particle sizes and shape were consistent with 
what was qualitatively observed in the histology. None 
of the periprosthetic tissue samples showed evidence of 
osteolysis in our series of explants. 
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